TUSC3 inhibitors constitute a class of chemical compounds that have the potential to inhibit the function of the Tumor Suppressor Candidate 3 (TUSC3) protein. TUSC3 is a component of the oligosaccharyltransferase (OST) complex, which is integral in the protein N-glycosylation process. By inhibiting TUSC3, these compounds can impact the function of the OST complex and, subsequently, the process of N-glycosylation.
TUSC3 would presumably bind to the protein, diminishing its function within the OST complex. TUSC3 inhibitors includes compounds that can interfere with the overall N-glycosylation process. These compounds might not interact directly with TUSC3, but their effects on the N-glycosylation pathway could indirectly inhibit TUSC3 function. For instance, compounds inhibiting the availability or function of the sugar carrier molecule dolichol phosphate might indirectly affect TUSC3 function by disrupting the overall N-glycosylation process.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Tunicamycin inhibits N-linked glycosylation, a process in which TUSC3 plays a key role. While it's primarily an inhibitor, this compound might indirectly affect TUSC3 activity by modulating the overall glycosylation pathway. | ||||||
Thiamet G | 1009816-48-1 | sc-224307 sc-224307A | 1 mg 5 mg | $52.00 $96.00 | 1 | |
Thiamet G inhibits O-GlcNAcase, an enzyme involved in protein O-GlcNAcylation. Changes in global O-GlcNAcylation levels can indirectly impact N-glycosylation and thus potentially influence TUSC3 activity. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG-132 inhibits proteasome activity, which can lead to the accumulation of misfolded proteins and trigger the unfolded protein response. This could potentially influence the activity of the OST complex and TUSC3. | ||||||